PMID: 7022456Jun 1, 1981Paper

Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans

Proceedings of the National Academy of Sciences of the United States of America
F M Griffin

Abstract

I have studied the roles of macrophage Fc and C3b receptors in the cell's interaction with encapsulated Cryptococcus neoformans and have defined the effects of a lymphokine that enhances macrophage complement receptor function, the effects of ingestion of soluble immune complexes, and the effects of corticosteroid treatment upon the ability of macrophages to phagocytize cryptococci via these receptors. Neither uncoated nor C3-coated cryptococci were phagocytized, whereas IgG-coated cryptococci were avidly phagocytized by mouse peritoneal macrophages. Treatment of macrophages with the lymphokine enabled them to ingest C3-coated cryptococci. Prior ingestion of soluble immune complexes severely compromised macrophages' ability to phagocytize cryptococci via their Fc receptors but did not affect their ability to ingest cryptococci via their complement receptors. Corticosteroid treatment severely impaired the ability of macrophages to respond to the lymphokine. Based upon these experimental observations, I have constructed a model for normal host defense mechanisms against disease due to C. neoformans.

References

Oct 1, 1978·Cellular Immunology·J R Graybill, D J Drutz
Sep 1, 1978·Immunochemistry·A K BhattacharjeeC P Glaudemans
Feb 1, 1977·The Journal of Experimental Medicine·A G Ehlenberger, V Nussenzweig
Jun 1, 1975·The Journal of Allergy and Clinical Immunology·S C Schimpff, J E Bennett
Jun 11, 1975·The Journal of Experimental Medicine·C BiancoS C Silverstein
Oct 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·R D DiamondJ E Bennett
Apr 1, 1972·The Journal of Infectious Diseases·R D DiamondJ E Bennett
Feb 1, 1974·Annals of Internal Medicine·R D Diamond, J E Bennett
Jan 1, 1971·The Journal of Infectious Diseases·L O Gentry, J S Remington
Jan 1, 1980·The Journal of Clinical Investigation·M A Horwitz, S C Silverstein

❮ Previous
Next ❯

Citations

Feb 1, 1986·Mycopathologia·R A Fromtling, H J Shadomy
Jul 15, 1982·Klinische Wochenschrift·T SchaffnerH Cottier
May 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T F Patterson, V T Andriole
Aug 1, 1990·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G S Deepe, W E Bullock
Jan 1, 1983·Springer Seminars in Immunopathology·H P Hartung, U Hadding
Jan 1, 1984·Folia Microbiologica·L Fornůsek, V Vĕtvicka
Jan 1, 1989·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·B Bolaños, T G Mitchell
Jul 1, 1997·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·D L GoldmanL S Zuckier
Dec 24, 1997·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·R K Li, T G Mitchell
Dec 1, 1984·The Journal of Experimental Medicine·L F FriesM M Frank
Jul 1, 1985·The Journal of Experimental Medicine·F M Griffin, P J Mullinax
Jul 1, 1995·Antimicrobial Agents and Chemotherapy·J MukherjeeA Casadevall
Apr 13, 2010·Eukaryotic Cell·Kerstin Voelz, Robin C May
Aug 1, 1985·The Journal of Clinical Investigation·D L GrangerD T Durack
Mar 21, 1998·Emerging Infectious Diseases·K L Buchanan, J W Murphy
Jan 1, 1987·Experimental Cell Research·J T DerksenG L Scherphof
Jan 1, 1985·Microbiology and Immunology·K KagayaS Saito
Apr 14, 2015·Future Microbiology·Soma Rohatgi, Liise-Anne Pirofski
Jan 10, 2018·Frontiers in Immunology·Shengjie Xu, Mari L Shinohara
Mar 4, 2006·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Kiyokazu FukuiTadami Matsumoto
Feb 24, 2001·Medical Mycology·A Vecchiarelli
Aug 1, 1983·Agents and Actions·A SobelY Gabay
Nov 1, 1991·Infection and Immunity·H L Collins, G J Bancroft
Oct 1, 1996·Clinical Microbiology Reviews·L H HoganS M Levitz
Jan 1, 1996·Clinical Microbiology Reviews·T R Kozel
Feb 1, 1985·Infection and Immunity·S P Targowski, W Klucinski
Jan 7, 2003·Infectious Disease Clinics of North America·Brahm H SegalFrancisco Menichetti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.